Stock Events

Stock Events

iSpecimen 

$0.15
0
+$0+3.03% Wednesday 07:21

Statistics

Day High
0.15
Day Low
0.14
52W High
-
52W Low
-
Volume
47,301
Avg. Volume
-
Mkt Cap
1.46M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5MayExpected
Q3 2025
Q4 2025
Next
-3.8
-3.47
-3.13
-2.8
Expected EPS
N/A
Actual EPS
N/A

Financials

-134.52%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
18.58MRevenue
-25MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ISPC.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a broad range of services and products for scientific research and healthcare, including specimen collection and processing, directly competing with iSpecimen's core services.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories provides a variety of products and services for life science research and clinical diagnostics, competing in the specimen collection and analysis market.
Mettler-Toledo International
MTD
Mkt Cap29.17B
Mettler-Toledo International is involved in precision instruments and services for professional use, including laboratory equipment that can be used in specimen analysis, overlapping with iSpecimen's market.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies provides instruments, services, consumables, applications, and expertise for laboratory workflow, including specimen analysis, making it a competitor.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics offers diagnostic testing services, including specimen collection and processing, directly competing with iSpecimen's services.
Labcorp
LH
Mkt Cap21.08B
Laboratory Corporation of America Holdings operates as a life sciences company and a direct competitor in clinical laboratory and end-to-end drug development services.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions that can be used in specimen analysis, competing with iSpecimen.
Waters
WAT
Mkt Cap20.81B
Waters Corporation produces analytical standards and reagents, chromatography columns, and sample preparation products, which are used in specimen analysis, making it a competitor.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing in the niche of specimen analysis for healthcare research and diagnostics, similar to iSpecimen's market focus.

About

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Show more...
CEO
ISIN
US45032V2079

Listings

XNAS
US
ISPC
BOATS
BOATS
ISPC.BOATS

0 Comments

Share your thoughts

FAQ

What is iSpecimen stock price today?▼
The current price of ISPC.BOATS is $0.15 USD — it has increased by +3.03% in the past 24 hours. Watch iSpecimen stock price performance more closely on the chart.
What is iSpecimen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange iSpecimen stocks are traded under the ticker ISPC.BOATS.
What is iSpecimen market cap?▼
Today iSpecimen has the market capitalization of 1.46M
When is the next iSpecimen earnings date?▼
iSpecimen is going to release the next earnings report on May 05, 2026.
What is iSpecimen revenue for the last year?▼
iSpecimen revenue for the last year amounts to 18.58M USD.
What is iSpecimen net income for the last year?▼
ISPC.BOATS net income for the last year is -25M USD.
When did iSpecimen complete a stock split?▼
iSpecimen has not had any recent stock splits.